MedDataX Logo

Accessibility of the World Health Organization's eTB Catalogue of Recommendations

NCT ID: NCT04745897

Last Updated: 2021-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

244 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-26

Study Completion Date

2021-08-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The World Health Organization's Global Tuberculosis Programme (WHO-GTB) issues evidence-informed guideline recommendations on tuberculosis (TB). These recommendations are used by decision-makers, guideline developers and other stakeholders. In an effort to improve the accessibility and usability of these recommendations, a new eTB catalogue of recommendations has been developed. This study aims to compare the accessibility of the new eTB catalogue to the earlier method of accessing recommendations directed through the general WHO website.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a two-arm superiority randomized controlled trial. The primary objective is to compare the accessibility of information between the eTB catalogue (intervention) and WHO TB (comparison). Secondary outcomes include understanding of the information, satisfaction of catalogue presentation, and preference toward the catalogue. Current and potential users of TB recommendations will be recruited. Data will be collected using a survey with demographic questions and subsequent 1:1 randomization to the intervention. Superiority will be declared if the mean difference in accessibility is 0.5 or greater for the intervention arm on the seven-point Likert scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

GRADE Guidelines Recommendations Recommendation Mapping Evidence Mapping

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

eTB Catalogue of Recommendation (eTB)

New eTB catalogue of recommendations website (eTB).

Group Type EXPERIMENTAL

eTB Catalogue of Recommendations (eTB)

Intervention Type OTHER

eTB Catalogue of Recommendations (eTB)

World Health Organization Tuberculosis Website (WHO TB)

Current method of accessing tuberculosis (TB) recommendations using World Health Organization (WHO) website (WHO TB).

Group Type ACTIVE_COMPARATOR

World Health Organization Tuberculosis Website (WHO TB)

Intervention Type OTHER

World Health Organization Tuberculosis Website (WHO TB)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

eTB Catalogue of Recommendations (eTB)

eTB Catalogue of Recommendations (eTB)

Intervention Type OTHER

World Health Organization Tuberculosis Website (WHO TB)

World Health Organization Tuberculosis Website (WHO TB)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stakeholders who consider themselves to be users or potential users of tuberculosis (TB) recommendations will be eligible for participation. For the purposes of this trial, a user is defined as someone who has previously accessed TB guidelines, recommendations or policy advice, and a potential user is someone who plans to access TB guidelines, recommendations, or policy advice in the future.
* Participants may be part of any group that has a stake in TB, including the public, healthcare providers, policymakers, or researchers. Participants may be from either low- and middle-income countries (LMIC) or high-income countries (HIC).
* They may also vary in levels of education and previous TB work experience.

Exclusion Criteria

* Individuals involved in eTB catalogue development.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

McMaster University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Holger J Schunemann, MD, PhD

Role: STUDY_CHAIR

McMaster University

Micayla N Matthews, BHSc

Role: PRINCIPAL_INVESTIGATOR

McMaster University

Tamara Lotfi, MD, MPH

Role: STUDY_DIRECTOR

McMaster University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

McMaster University

Hamilton, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Matthews M, Lotfi T, Santesso N, Loeb M, Mertz D, Chagla Z, Hajizadeh A, Piggott T, Dietl B, Schunemann HJ. Comparing the usability of the World Health Organization's conventional tuberculosis guidelines to the eTB recommendations map: A two-arm superiority randomised controlled trial. PLOS Glob Public Health. 2022 Oct 14;2(10):e0001166. doi: 10.1371/journal.pgph.0001166. eCollection 2022.

Reference Type DERIVED
PMID: 36962671 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://tuberculosis.evidenceprime.com/

eTB Catalogue of Recommendations

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7908

Identifier Type: -

Identifier Source: org_study_id